checkAd

     105  0 Kommentare Biophytis To Take Appropriate Measures After Receiving Nasdaq Deficiency Notice - Seite 2

    Disclaimer

    This press release contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. In some cases, you can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "could," "seeks," "predicts," "intends," "trends," "plans," "estimates," "anticipates" or the negative version of these words or other comparable words. Such forward-looking statements are based on assumptions that Biophytis considers to be reasonable. However, there can be no assurance that the statements contained in such forward-looking statements will be verified, which are subject to various risks and uncertainties. The forward-looking statements contained in this press release are also subject to risks not yet known to Biophytis or not currently considered material by Biophytis. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Please also refer to the "Risk and uncertainties the Company is to face" section from the Company's 2021 Half Year Financial Report available on BIOPHYTIS website (www.biophytis.com) and as exposed in the "Risk Factors" section of form 20-F as well as other forms filed with the SEC (Securities and Exchange Commission, USA). We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

    Biophytis Contact for Investor Relations

    Philippe Rousseau CFO

    Investors@biophytis.com

    Media Contacts

    Antoine Denry:antoine.denry@taddeo.fr +33 6 18 07 83 27
    Agathe Boggio:agathe.boggio@taddeo.fr +33 7 62 77 69 42

    SOURCE: Biophytis



    View source version on accesswire.com:
    https://www.accesswire.com/735001/Biophytis-To-Take-Appropriate-Measur ...


    at the time of publication of the news with a fall of -5,91 % to 0,414 on Frankfurt stock exchange (11. Januar 2023, 16:12 Uhr).
    Seite 2 von 2




    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Biophytis To Take Appropriate Measures After Receiving Nasdaq Deficiency Notice - Seite 2 PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / January 12, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow …

    Schreibe Deinen Kommentar

    Disclaimer